Karyopharm Therapeutics (KPTI) Company Statistics | The Fly

Search...

/

Dashboard

Charting

KPIs

Stock Screener

ETF Screener

Earnings Calendar

Events Calendar

Syndicate

Street Research

Portfolios

Alert Settings

© 2026 The Fly Inc.

The Fly Cast

Press play to listen

©

Karyopharm Therapeutics (KPTI) Company Statistics | The Fly

Karyopharm Therapeutics

· KPTI

Dashboard

Financials

KPIs

Ratios

Transcripts

Valuation

Statistics

27.331 M

+1.24%

General

Market Cap: $27.33M
Enterprise Value: $188.55M
Shares Outstanding: 22,660,000
Dividend: —
Employees: —
Revenue Per Employee: —

Fundamental Ratios (TTM)

Gross Margin: 95.88%
Operating Margin: -56.17%
Net Profit Margin: -153.28%
FCF Margin: -44.57%
ROA: -201.89%
ROE: 77.63%
ROIC: 376.87%
Current Ratio: 0.79
Debt-to-Equity: -0.65
Revenue Per Employee: —

Valuation (TTM)

P/E: —
PEG: —
P/S: 0.19
P/FCF: —
P/B: —
EV/EBITDA: -1.07

Growth

Rev 1Y: 0.57%
Rev 1Y Fwd Est: -6.56%
Rev 3Y (CAGR): -2.39%
Rev 5Y (CAGR): 6.21%
Rev 10Y (CAGR): 89.09%
EPS 1Y: —
EPS 1Y Fwd Est: —
EPS 3Y (CAGR): —
EPS 5Y (CAGR): —
EPS 10Y (CAGR): —

Income Statement (TTM)

Revenue: $146.62M
Gross Margin: 95.88%
Operating Expenses: $222.93M
Operating Income: -$82.35M
Net Profit: -$224.74M

Balance Sheet

Cash and Equivalents: $54.98M
Working Capital: -$27.86M
Total Assets: $111.32M
Net Debt: $160.91M
Total Liabilities: $441.49M
Total Equity: -$330.17M

Cash Flow Statement (TTM)

Cash Flow from Operations: -$65.35M
Cash Flow from Investing: $2.97M
Cash Flow from Financing: $78.6M
Free Cash Flow: -$65.35M
Capital Expenditures: $0